Midwest Oncology Consortium — Kansas City, Missouri

Midwest Oncology Consortium is a clinical research site located in Kansas City, Missouri, United States 64111.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Midwest Oncology Consortium has participated in 3 clinical trials.

Therapeutic areas: Pancreatic Cancer, Colorectal Cancer, Melanoma (Skin).

Sponsors: NCIC Clinical Trials Group, Sanofi, AVAX Technologies.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Midwest Oncology Consortium?

Midwest Oncology Consortium has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Midwest Oncology Consortium conducted?

Midwest Oncology Consortium has 3 clinical trials on record. Their work covers Pancreatic Cancer, Colorectal Cancer, Melanoma (Skin).

Is Midwest Oncology Consortium accredited by Crixeo Health?

Midwest Oncology Consortium has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Midwest Oncology Consortium?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.